We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Precision Tracking of Samples Enabled at Low Temperatures

By LabMedica International staff writers
Posted on 28 Feb 2012
A new solution enables real-time (RT) precision tracking of samples in situ at low temperatures.

Difficulties in tracking samples are due to the inability to locate automatically the samples, as well as a lack of robust connection between the physical sample and archiving software. More...
The task is further complicated at ultra low temperatures.

The ColdTrack platform was designed to solve these problems. The platform enables electronic tracking by associating a unique electronic tag with each sample, enabling fast mapping of sample boxes.
Tens of millions of new biological samples are collected and stored annually by pharmaceutic companies, universities, hospitals, diagnostic testing and research centers, national genetic databases, and forensic laboratories.

BioTillion (Skillman, NJ, USA), a privately held company, introduced the ColdTrack platform at the SLAS 2012 meeting in San Diego (CA, USA), which was held in February 2012.

Each ColdTrack sample vial has unique radio frequency identification (RFID) tag that cannot be changed or replicated in another, and contains user-defined data that may be modified by a user. The RFID-tagged vials survive exposure to a wide range of temperatures: from liquid nitrogen temperatures (-196 °C) up to the maximum operating temperature of the vial (121 °C) without loss of data or functionality.

A freezer box is mapped by placing the box containing one or more ColdTrack vials on a BoxMapper. The BoxMapper can map the contents of an 81-sample freezer box in about a second. The reader is connected to a computer using a USB cable.

The BoxMapper is integrated with a group of laboratory information-management systems (LIMS) packages. The details of the CDR-LIMS interaction is slightly different for each LIMS package but in all cases the box contents are transferred to the LIMS program automatically so that the user does not need to enter vial IDs or box locations.

Related Links:
BioTillion
SLAS 2012 meeting


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.